Co-targeting of miR-126-3p and miR-221-3p inhibits PIK3R2 and PTEN, reducing lung cancer growth and metastasis by blocking AKT and CXCR4 signaling

Published on Jun 9, 2021in Molecular Oncology6.574
· DOI :10.1002/1878-0261.13036
Daniela Di Paolo22
Estimated H-index: 22
(Istituto Giannina Gaslini),
Francesca Pontis + 14 AuthorsCristina Borzi8
Estimated H-index: 8
Sources
Abstract
Lung cancer is the leading cause of cancer-related death worldwide. Late diagnosis and metastatic dissemination contribute to its low survival rate. Since microRNA (miRNA) deregulation triggers lung carcinogenesis, miRNAs might represent an interesting therapeutic tool for lung cancer management. We identified seven miRNAs, including miR-126-3p and miR-221-3p, that are deregulated in tumours compared with normal tissues in a series of 38 non-small-cell lung cancer patients. A negative correlation between these two miRNAs was associated with poor patient survival. Concomitant miR-126-3p replacement and miR-221-3p inhibition, but not modulation of either miRNA alone, reduced lung cancer cell viability by inhibiting AKT signalling. PIK3R2 and PTEN were validated as direct targets of miR-126-3p and miR-221-3p, respectively. Simultaneous miRNA modulation reduced metastatic dissemination of lung cancer cells both in vitro and in vivo through CXCR4 inhibition. Systemic delivery of a combination of miR-126-3p mimic and miR-221-3p inhibitor encapsulated in lipid nanoparticles reduced lung cancer patient-derived xenograft growth through blockade of the PIK3R2-AKT pathway. Our findings reveal that co-targeting miR-126-3p and miR-221-3p to hamper both tumour growth and metastasis could be a new therapeutic approach for lung cancer.
📖 Papers frequently viewed together
29 Citations
26 Citations
4 Authors (Wenxia Hu, ..., Wei Liu)
11 Citations
References41
Newest
#1Crescenzo D'AlterioH-Index: 18
#2Antonella ZannettiH-Index: 22
Last. Stefania ScalaH-Index: 36
view all 20 authors...
The chemokine receptor CXCR4 is overexpressed and functional in colorectal cancer. To investigate the role of CXCR4 antagonism in potentiating colon cancer standard therapy, the new peptide CXCR4 antagonist Peptide R (Pep R) was employed. Human colon cancer HCT116 xenograft-bearing mice were treated with chemotherapeutic agents (CT) 5-Fluorouracil (5FU) and oxaliplatin (OX) or 5FU and radio chemotherapy (RT-CT) in the presence of Pep R. After two weeks, CT plus Pep R reduced by 4-fold the relati...
2 CitationsSource
#1Daniela Di Paolo (Istituto Giannina Gaslini)H-Index: 22
#1D. Di Paolo (Istituto Giannina Gaslini)H-Index: 5
Last. Patrizia Perri (Istituto Giannina Gaslini)H-Index: 22
view all 20 authors...
Neuroblastoma (NB) tumor substantially contributes to childhood cancer mortality. The design of novel drugs targeted to specific molecular alterations becomes mandatory, especially for high-risk patients burdened by chemoresistant relapse. The dysregulated expression of MYCN, ALK, and LIN28B and the diminished levels of miR-34a and let-7b are oncogenic in NB. Due to the ability of miRNA-mimics to recover the tumor suppression functions of miRNAs underexpressed into cancer cells, safe and efficie...
7 CitationsSource
#1Massimo MoroH-Index: 17
#2Daniela Di Paolo (Istituto Giannina Gaslini)H-Index: 22
Last. Orazio FortunatoH-Index: 11
view all 12 authors...
Abstract Lung cancer is the leading cause of cancer-related deaths. Late diagnosis and inadequate therapies contribute to poor outcomes. MicroRNAs (miRNAs) are small non-coding RNAs and are involved in lung cancer development. Because miRNAs simultaneously regulate several cancer-related genes, they represent an interesting therapeutic approach for cancer treatment. We have developed Coated Cationic Lipid-nanoparticles entrapping miR-660 (CCL660) and intraperitoneally administered (1.5 mg/Kg) tw...
17 CitationsSource
#1Gloria Ravegnini (UNIBO: University of Bologna)H-Index: 15
#2Sarah CargninH-Index: 12
Last. Sabrina Angelini (UNIBO: University of Bologna)H-Index: 29
view all 8 authors...
Background: A wealth of evidence has shown that microRNAs (miRNAs) can modulate specific genes, increasing our knowledge on the fine-tuning regulation of protein expression. miR-221 and miR-222 have been frequently identified as deregulated across different cancer types; however, their prognostic significance in cancer remains controversial. In view of these considerations, we performed an updated systematic review and meta-analysis of published data investigating the effects of miR-221/222 on o...
16 CitationsSource
#1Orazio FortunatoH-Index: 11
#2Cristina BorziH-Index: 8
Last. Gabriella SozziH-Index: 71
view all 20 authors...
: miRNAs play a central role in the complex signaling network of cancer cells with the tumor microenvironment. Little is known on the origin of circulating miRNAs and their relationship with the tumor microenvironment in lung cancer. Here, we focused on the cellular source and relative contribution of different cell types to circulating miRNAs composing our risk classifier of lung cancer using in vitro/in vivo models and clinical samples. A cell-type specific expression pattern and topography of...
27 CitationsSource
#1Luis M. Seijo (University of Navarra)H-Index: 19
#1Luis M. Seijo (University of Navarra)H-Index: 9
Last. Luis M. MontuengaH-Index: 58
view all 12 authors...
Abstract The present review is an update of the research and development efforts regarding the use of molecular biomarkers in the lung cancer screening setting. The two main unmet clinical needs, namely, the refinement of risk to improve the selection of individuals undergoing screening and the characterization of undetermined nodules found during the computed tomography–based screening process are the object of the biomarkers described in the present review. We first propose some principles to ...
95 CitationsSource
#1Nanako KawaguchiH-Index: 9
#1Nanako KawaguchiH-Index: 9
Last. Toshio NakanishiH-Index: 28
view all 3 authors...
CXC motif chemokine receptor type 4 (CXCR4) is associated with normal and abnormal development, including oncogenesis. The ligand of CXCR4 is stromal cell-derived factor (SDF), also known as CXC motif ligand (CXCL) 12. Through the SDF-1/CXCR4 axis, both homing and migration of hematopoietic (stem) cells are regulated through niches in the bone marrow. Outside of the bone marrow, however, SDF-1 can recruit CXCR4-positive cells from the bone marrow. SDF/CXCR4 has been implicated in the maintenance...
40 CitationsSource
#1Mattia BoeriH-Index: 21
#2Massimo MilioneH-Index: 31
Last. Gabriella SozziH-Index: 71
view all 14 authors...
Purpose: Immune-checkpoint inhibitors (ICI) have improved the survival of patients with non–small cell lung cancer (NSCLC). However, only a subset of patients benefit from ICIs, and the role of PD-L1 as predictive biomarker is still debated. A plasma immune-related miRNA-signature classifier (MSC) was established in lung cancer screening settings to identify the lethal form of the disease in early stages. In this exploratory study, we tested the efficacy of the MSC as prognostic marker in patien...
32 CitationsSource
#1Rebecca L. Siegel (ACS: American Cancer Society)H-Index: 67
#2Kimberly D. Miller (ACS: American Cancer Society)H-Index: 28
Last. Ahmedin Jemal (ACS: American Cancer Society)H-Index: 139
view all 3 authors...
: Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States and compiles the most recent data on cancer incidence, mortality, and survival. Incidence data, available through 2015, were collected by the Surveillance, Epidemiology, and End Results Program; the National Program of Cancer Registries; and the North American Association of Central Cancer Registries. Mortality data, available through 2016, were collected by the Nati...
9,825 CitationsSource
#1Franziska EckertH-Index: 18
#2Karin SchilbachH-Index: 20
Last. Stephan M. HuberH-Index: 62
view all 8 authors...
Cancer immunotherapy has been established as standard of care in different tumor entities. After the first reports on synergistic effects with radiotherapy and the induction of abscopal effects – tumor shrinkage outside the irradiated volume attributed to immunological effects of radiotherapy – several treatment combinations have been evaluated. Different immunotherapy strategies (e.g. immune checkpoint inhibition, vaccination, cytokine based therapies) have been combined with local tumor irradi...
57 CitationsSource
Cited By0
Newest